These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7420089)

  • 1. Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy.
    Carter B; Harrison R; Lunt GG; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):397-402. PubMed ID: 7420089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
    Hawkey CJ; Newsom-Davis J; Vincent A
    J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):469-75. PubMed ID: 7276959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term follow-up study of anti-acetylcholine receptor antibody titers and clinical symptoms in patients with myasthenia gravis].
    Komiya T; Sato T
    Rinsho Shinkeigaku; 1988 Jul; 28(7):727-34. PubMed ID: 3233845
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of anti-acetylcholine receptor antibodies in myasthenia and its treatment by plasma exchange and immunosuppressants].
    Goulon M; Gajdos P; Goulon C; Bussel A; Morel E; Raimond F; Estournet B
    C R Seances Soc Biol Fil; 1980; 174(4):467-78. PubMed ID: 6449232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis.
    Milner-Brown HS; Miller RG
    J Neurol Sci; 1982 Dec; 57(2-3):357-68. PubMed ID: 6298372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis.
    Roses AD; Olanow CW; McAdams MW; Lane RJ
    Neurology; 1981 Feb; 31(2):220-4. PubMed ID: 7193309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.
    Lefvert AK; Bergström K; Matell G; Osterman PO; Pirskanen R
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):394-403. PubMed ID: 207825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lipid-associated acetylcholine receptor as an antigen in diagnosis of myasthenia gravis.
    Raimond F; Vernet-der-Garabedian B; Morel E
    Clin Exp Immunol; 1982 Feb; 47(2):345-50. PubMed ID: 7075027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
    Seybold ME; Baergen RN; Nave B; Lindstrom JM
    Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of repeated plasma exchange in myasthenia gravis.
    Newsom-Davis J; Wilson SG; Vincent A; Ward CD
    Lancet; 1979 Mar; 1(8114):464-8. PubMed ID: 85055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy for anti-MuSK antibody positive myasthenia gravis].
    Pál Z; Boczán J; Bereznai B; Lovas G; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1586-9. PubMed ID: 21920845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-acetylcholine and anti-receptor antibodies in myasthenia].
    Lebrun-Grandie P; Souan ML; Geffard M; Dartigues JF; Mauricet B; Orgogozo JM
    Presse Med; 1987 Oct; 16(32):1577-80. PubMed ID: 2958833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
    Suga M; Akahonai Y; Tsujisaki M; Mori M; Yoshizaki H; Matsumoto H; Yachi A
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
    Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
    No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
    [No Abstract]   [Full Text] [Related]  

  • 18. An assessment of radioimmunoassay procedures for determination of anti-acetylcholine receptor antibodies in the sera of patients with myasthenia gravis.
    Carter B; Harrison R; Lunt GG; Morris H; Savage-Marengo T; Stephenson FA
    Ann Clin Biochem; 1981 May; 18(Pt 3):146-52. PubMed ID: 7283364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody-controlled cytostatic therapy of malignant thymoma with concomitant myasthenia gravis].
    Schumm F; Brinkmann A; Fateh-Moghadam A
    Dtsch Med Wochenschr; 1984 Aug; 109(33):1244-6. PubMed ID: 6547902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; The TH
    J Neurol Sci; 1983 Mar; 58(3):371-85. PubMed ID: 6842265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.